Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-022748
Filing Date
2009-02-10
Accepted
2009-02-09 18:34:42
Documents
11
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #2 d10ka.htm 10-K/A 729560
2 CODE OF ETHICS dex141.htm EX-14.1 29901
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5857
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6267
5 SECTION 906 CEO/CFO CERTIFICATION dex32.htm EX-32 4289
6 GRAPHIC g18513ex14_1.jpg GRAPHIC 2919
7 GRAPHIC g18513img-tx10a.jpg GRAPHIC 149865
8 GRAPHIC g18513img-tx10b.jpg GRAPHIC 110354
9 GRAPHIC g18513img-tx11a.jpg GRAPHIC 120333
10 GRAPHIC g18513img-tx11b.jpg GRAPHIC 137431
11 GRAPHIC g18513img-tx9.jpg GRAPHIC 81300
  Complete submission text file 0001193125-09-022748.txt   1607930
Mailing Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607
Business Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607 813-600-4088
Stem Cell Therapy International, Inc. (Filer) CIK: 0001360479 (see all company filings)

EIN.: 880374180 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51931 | Film No.: 09582580
SIC: 8071 Services-Medical Laboratories